Upload
ketan
View
33
Download
0
Tags:
Embed Size (px)
DESCRIPTION
Type I Diabetes. Kris Hinnerichs. Diabetes Mellitus. A condition where the body is no longer able to control the glucose levels in the blood stream ~16 mill. cases in the United States 5-10% of those cases are type I Half of these cases are under age 20. Physiology. Endocrine is Greek - PowerPoint PPT Presentation
Citation preview
Diabetes Mellitus A condition where the body is no
longer able to control the glucose levels in the blood stream
~16 mill. cases in the United States 5-10% of those cases are type I Half of these cases are under age
20
Physiology Endocrine is Greek
Endo = within Krino = to separate
Intercellular chemical signals are produced within and secreted from endocrine glands, but have an effect away from the gland
Only effects target cells
Negative FeedbackHomeostasis of blood glucose levels
Blood glucose levels increase after a meal Insulin is secreted
Insulin causes tissues to take up glucose blood glucose levels decline
Rate of insulin secretion declines too rate of blood glucose uptake decreases
Endocrine Part of Pancreas Pancreatic islets (islets of
Langerhans) dispersed among exocrine portion
Beta cells secrete insulin Alpha cells secrete glucagon
Both work to regulate blood nutrient levels
Low Blood Glucose Levels Nervous system malfunctions Fats and proteins are broken down
causing ketoacidosis pH drops Ketones enter the blood stream
Amino acids are broken down and used to synthesize glucose by the liver
High Blood Glucose Levels Kidneys produce large volumes of
urine Urine is high in glucose molecules Frequent urination can lead to
dehydration
Insulin Secretion Increase
Elevated blood glucose levels
Parasympathetic stimulation / digestion
Blood levels of certain amino acids
Decrease Decreased
blood glucose levels
Sympathetic stimulation / exercise
Target Cells / Tissues Liver Adipose tissues Muscles Satiety center of hypothalamus
Glucose is converted to glycogen or fat, and the amino acids are used to synthesize protein
Glucagon Released from alpha cells when blood
glucose levels are low Bind to membrane-bound receptors in
the liver to cause the conversion of glycogen stored in the liver to glucose
Glucose is then released into the blood to increase blood glucose levels
Effects of Insulin and Glucagon on Target Tissues
Target Tissues Insulin Responses Glucagon Responses
Skeletal muscle, cardiac muscle, cartilage, bone fibroblasts, blood cells and mammary glands
Increases glucose uptake and glycogen synthesis; increases uptake of amino acids
Has little effect
Liver Increases glycogen synthesis; increases use of glucose for energy
Causes rapid increase in the breakdown of glycogen to glucose and release of glucose into the blood; increases the formation of glucose from amino acids and, to some degree, from fats; increases metabolism of fatty acids
Adipose cells Increases glucose uptake, glycogen synthesis, fat synthesis
High concentrations cause breakdown of fats; probably unimportant under conditions
Nervous system Has little effect except to increase glucose uptake in the satiety center
Has no effect
Blood Glucose-Raising Hormones During Exercise
Hormone Source Main Actions During Exercise
Epinephrine Adrenal Medulla Stimulation of muscle, and to a lesser extend, liver, glycogen breakdown, and mobilization of free fatty acids from adipose tissues; more is released with increasing exercise intensity
Norepinephrine Adrenal Medulla, Sympathetic Nerve Endings
Stimulation of liver to produce new glucose from available precursors; “feedforward” control of glucose along with epinephrine
Glucagon Pancreas Stimulation of liver glycogen breakdown and new glucose production from precursors to increase glucose output; changes in the insulin to glucagons ration largely affect glycemia
Growth Hormone Anterior Pituitary Direct stimulation of fat metabolism (release of free fatty acids from adipose) and indirect suppression of glucose use; stimulation of amino acid storage
Cortisol Adrenal Cortex Mobilization of amino acids and glycerol as precursors for hepatic glucose production and release of free fatty acids for muscle use
Pathophysiology Diabetes mellitus is characterized by
glucose concentrations in the blood that are high enough to overwhelm the reabsorption capabilities of the kidneys
Glycosuria—glucose in urine Polyuria—excessive urine production Other metabolic products are
present in abnormal concentrations
Causes Researchers are uncertain of causes Possibilities:
Genetic abnormalities Pathological conditions Injuries Immune disorders Hormonal imbalances Secretion of too little insulin Insufficient numbers of insulin receptors Defective receptors
Without Insulin… Cells cannot absorb glucose After meals, blood concentrations
become so elevated that the kidneys cannot reclaim all the glucose
High urinary concentrations of glucose limit ability to conserve water
High urinary concentrations of glucose cause frequent urination and possible dehydration
Without insulin… Chronic dehydration can cause
neural function and muscle weakness
Satiety center of brain responds with an exaggerated appetite
Endocrine tissues respond with more glucose
Ketoacidosis results
Long Term Therapy Dietary control and insulin Complications:
Tissue glucose demands cycle Meals Physical activity Emotional state Stress Other unpredictable factors
Diabetic Coma Cause—loss of NA+, K+, and ketone
bodies through excessive urination S/S—labored breathing, gasping for
air, fruity –smelling breath, nausea, vomiting, thirst, flushed skin, confusion, unconsciousness
Care—early detection of ketoacidosis, injection of insulin
Insulin Shock Cause—too much insulin in the body
results in hypoglycemia S/S—tingling sensations, physical
weakness, headaches, abdominal pain, rapid HR, tremors, drowsiness
Care—adhere to a carefully planned diet with a snack before activity, keep a sugar source available
Pharmacology Insulin is the main drug Insulin is a protein hormone and
must be injected
Refer to charts in handout
Exercise and Type I Diabetes Controversial Does not improve glycemic control Reduce the risk of complications
due to diabetes Before beginning any program,
make sure to undergo a medical evaluation Macrovascular complications Microvascular complications
Cardiovascular System A graded exercise test may be helpful
Age > 35 Type I diabetes of > 15 years Presence of any additional risk factors for
coronary artery disease Presence of microvascular disease Peripheral vascular disease Autonomic neuropathy
PAD
Peripheral Arterial Disease Evaluation is based on signs and
symptoms Intermittent claudication Cold feet Decreased or absent pulses Atrophy of subcutaneous tissues Hair loss
Retinopathy The eye examination schedule
should follow the ADA’s Clinical Practice Guidelines See chart
Those with proliferative diabetic retinopathy should avoid strenuous exercise Anaerobic exercise Exercise involving straining, jarring,
or Valsalva-like maneuvers
RetinopathyLevel of DR Acceptable
ActivitiesDiscouraged
ActivitiesOcular Reevaluation
No DR Dictated by medical status Dictated by medical status 12 months
Mild NPDR Dictated by medical status Dictated by medical status 6-12 months
Moderate NPDR Dictated by medical status Activities that dramatically elevate blood pressure: Power lifting Heavy Valsalva
4-6 months
Severe NPDR Dictated by medical status Activities that substantially increase systolic blood pressure, Valsalva maneuvers, and active jarring: Boxing Heavy competitive sports
2-4 months (may require laser surgery)
PDR Low-impact cardiovascular conditioning: Swimming Walking Low-impact aerobics Stationary cycling Endurance exercises
Strenuous activities, Valsalva maneuvers, pounding or jarring: Weight lifting Jogging High-impact aerobcs Racquet sports Strenuous trumpet playing
1-2 months (may require laser surgery)
NPDR = nonproliferative diabetic retinopathy PDR = Proliferative diabetic retinopathy
Nephropathy Specific exercise recommendations
have not been developed for patients with incipient or overt nephropathy
High-intensity or strenuous exercise should be avoided
Peripheral Neuropathy Loss of sensation in the feet Limits weight-bearing exercises
ContraindicatedTreadmillProlonged walkingJoggingStep exercises
RecommendedSwimmingBicyclingRowingChair exercisesArm exercisesOther non-weight bearing exercises
Autonomic Neuropathy Cardiac Autonomic Neuropathy
Resting tachycardia Orthostasis (fall in SBP >20 mmHg upon
standing) Other disturbances in autonomic nervous
system function involving the skin, pupils, GI, or genitourinary systems
Sudden death Silent myocardial ischemia Hypo/hypertension after vigorous exercise Difficulty with thermoregulation
Effects of Diabetic Autonomic Neuropathy on Exercise Silent myocardial ischemia Resting tachycardia and decreased
maximal responsiveness Decreased heart-rate variability Orthostasis/hypotension with exercise Exaggerated blood pressure responses
with supine position and exercise Loss of diuranal blood pressure
variation
Effects of Diabetic Autonomic Neuropathy on Exercise Cardiovascular and cardiorespiratory
instability Abnormal systolic ejection fractions at
rest/exercise Poor exercise tolerance Failure of pupil adaption to darkness Gastroparesis and diabetic diarrhea Hypoglycemia Decreased hypoglycemia awareness
Effects of Diabetic Autonomic Neuropathy on Exercise Hypoglycemia unresponsiveness Heat intolerance due to defective
sympathetic thermoregulation and sweating
Susceptibility to foot ulcers and limb loss due to disordered regulation of cutaneous blood flow
Incontinence
Exercise Precautions Postpone exercise if blood glucose
>300mg/dL or >240 mg/dL with urinary ketone bodies
Especially when beginning a program, monitor blood glucose before, during, and after exercise if taking insulin or oral agents
Adjustments in carbohydrate intake and/or insulin may be needed before testing and training; ingest carbohydrate if blood glucose is <80-100 mg/dL
Exercise Precautions Select proper footwear and follow appropriate
foot care steps to prevent ulcerations and other lesions of the foot
Wear shoes with silica gel or air mid-soles Wear polyester or blend (cotton/polyester)
socks to prevent blisters Keep the feet dry Ensure proper fitting footwear
Exercise Precautions Wear a diabetes identification bracelet
or shoe tag when exercising, and it should be clearly visible at all times
Avoid extremely hot or cold environments
Maintain proper hydration before, during, and after exercise
Exercise Precautions High resistance exercise using weights
are not acceptable for older individuals or those with long standing diabetes
Moderate weight training programs that utilize light weights and high repetitions can be used for all patients with diabetes
Guidelines for Avoiding Hypoglycemia
Consume carbohydrates (15-30 g) for every 30 minutes of moderate-intensity exercise
Consume a snack of slowly absorbed carbohydrate following prolonged exercise sessions
Avoid exercising muscle that underlies the injection site of short-acting insulin for 1 hour
Avoid late evening exercise
Guidelines for Avoiding Hypoglycemia
Decrease the insulin does: Intermediate-acting insulin—decrease by 30-35% on
the day of exercise Intermediate- and short-acting insulin—omit the dose of
short-acting insulin that precedes exercise Multiple doses of short-acting insulin—reduce the dose
prior to exercise by 30-50% and supplement carbohydrates
Continuous subcutaneous infusion—eliminate the mealtime bolus or increment that precedes or immediately follows exercise
Common Hypoglycemic Symptoms During Exercise Double or blurred
vision Abnormally elevated
pulse Fatigue Hand tremors /
shakiness Headache
Mental confusion Poor physical
coordination Tingling of hands or
tongue Visual spots Weakness
Refer to Charts Factors affecting blood glucose
management for acute and chronic exercise
Cardiopulmonary response to symptom-limited graded exercise in diabetics and controls
General Carbohydrate Increases for Endurance Activities
Preparing for Exercise Proper warm-up of 5-10 minutes of aerobic
activity at a low intensity level Stretch for 5-10 minutes, primarily focusing
on muscles that will be used during the exercise session
Cool down after the exercise session, taking about 5-10 minutes to gradually bring the heart rate down to its preexercise level
Exercise Prescription Frequency: 4-6 days per week or daily at low to
moderate intensity Duration: 20-60 minutes per session Intensity: 50-85% VO2max May need to use perceived exertion as an adjunct
to heart rate for monitoring exercise intensity. Exercising late in the evening increases risk of
nocturnal hypoglycemia Exercise caution when exercising in hot weather